Associate Director, Market Access Analytics
Madrigal Pharmaceuticals
Summary
The Associate Director, Market Access Analytics leads payer, formulary, and coverage analytics for Madrigal's Commercial organization, turning access and contracting data into insight that guides Market Access strategy for the MASH portfolio. Reporting to the Senior Director, Market Access, Trade & IDN Analytics, this role owns the payer analytics and reporting agenda — measuring formulary access, coverage, utilization management, and contract performance at national and sub-national levels — and serves as a trusted analytics partner to Managed Markets, Patient Services, Trade, and Finance. This individual translates complex payer dynamics into clear, actionable guidance for leadership and field teams.
Job description
Role & Responsibilities
- Own and evolve the payer analytics and KPI framework across formulary access, coverage, utilization management, payer/channel segmentation mix, and contract performance — with consistent definitions and tracking at both national and local levels.
- Analyze formulary positioning, covered lives, payer policy trends, and PA/step-edit and other utilization-management dynamics; translate access challenges into strategic guidance for leadership and field teams.
- Develop analytics and reporting on payer channel performance, projected plan performance, and pull-through to inform short-term tactical decisions and long-term access strategy.
- Support gross-to-net, contract, and rebate analytics — including bid evaluation, break-even / return-on-contract scenarios, and the net-revenue impact of formulary access assumptions.
- Partner with Patient Services and Trade on copay/affordability program analytics and specialty pharmacy dynamics affecting patient access and the patient journey.
- Build and maintain executive-ready dashboards and reporting, and own mappings across formulary, claims, and projected-plan-performance data sources.
- Serve as a strategic analytics partner to Managed Markets, Patient Services, Trade, Finance, and the broader Commercial team, translating business questions into structured analyses.
- Partner with data enablement and IT to ensure robust data infrastructure for payer analytics, and manage relationships with access-data vendors.
Qualifications
- Bachelor's degree in a quantitative, business, or related field; advanced degree preferred.
- 8+ years of pharmaceutical or biotech commercial analytics experience, including dedicated experience in market access / payer analytics.
- Strong knowledge of access-related datasets (e.g., MMIT, DRG, claims, specialty pharmacy, distribution, and contracting data).
- Demonstrated ability to build KPI frameworks, dashboards, and executive-ready reporting.
- Hands-on proficiency in SQL and data visualization tools (e.g., Power BI, Tableau); Python a plus.
- Working knowledge of gross-to-net and contract/rebate analytics.
Preferred Experience
- Experience supporting specialty or rare disease brands, ideally through launch.
- Familiarity with patient services data and platforms (e.g., CoverMyMeds, ConnectiveRx, copay/hub data).
- Experience with gross-to-net and contracting platforms (e.g., Model N, MMIT, IntegriChain).
- Experience partnering with Managed Markets and field access teams.
Skills & Competencies
- Ability to translate complex payer dynamics into clear, actionable insight for senior leaders and field teams.
- Strong analytical and critical-thinking skills with attention to data accuracy and consistent definitions.
- Effective stakeholder management across a matrixed Commercial organization.
- Self-directed ownership of analytics projects end to end.
Requirements
- Bachelor's degree in a quantitative, business, or related field; advanced degree preferred.
- 8+ years of pharmaceutical or biotech commercial analytics experience, including dedicated experience in market access / payer analytics.
- Strong knowledge of access-related datasets (e.g., MMIT, DRG, claims, specialty pharmacy, distribution, and contracting data).
- Demonstrated ability to build KPI frameworks, dashboards, and executive-ready reporting.
- Hands-on proficiency in SQL and data visualization tools (e.g., Power BI, Tableau); Python a plus.
- Working knowledge of gross-to-net and contract/rebate analytics.
- Preferred: Experience supporting specialty or rare disease brands, ideally through launch.
- Preferred: Familiarity with patient services data and platforms (e.g., CoverMyMeds, ConnectiveRx, copay/hub data).
- Preferred: Experience with gross-to-net and contracting platforms (e.g., Model N, MMIT, IntegriChain).
- Preferred: Experience partnering with Managed Markets and field access teams.
- Ability to translate complex payer dynamics into clear, actionable insight for senior leaders and field teams.
- Strong analytical and critical-thinking skills with attention to data accuracy and consistent definitions.
- Effective stakeholder management across a matrixed Commercial organization.
- Self-directed ownership of analytics projects end to end.
Benefits
- Flexible PTO
- Medical, Dental & Vision
- Life & Disability Insurance
- 401(k) with match
- Equity
- Mental Health Benefits
- Employee Assistance Program
- Supplemental Life Insurance
- Legal Services
Company overview
Madrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), formerly known as non-alcoholic steatohepatitis (NASH), a serious form of fatty liver disease. The company's lead product, Rezdiffra (resmetirom), is a once-daily, oral thyroid hormone receptor (THR)-β selective agonist that targets key underlying causes of MASH in the liver. Rezdiffra received FDA approval in 2024 as the first treatment for MASH with moderate to advanced liver fibrosis, representing a significant breakthrough in hepatology. Headquartered in Conshohocken, Pennsylvania, Madrigal is publicly traded on NASDAQ under the symbol MDGL. The company continues to advance its clinical development programs, including ongoing Phase 3 trials evaluating Rezdiffra for the treatment of compensated MASH cirrhosis. Madrigal's innovative approach addresses a critical unmet medical need in liver disease therapeutics.